PDI - Resultado de Búsqueda

RODRIGO ALBERTO ALONSO KARLEZI

Director Jefe Departamento

Clínica Las Condes

Santiago, Chile

Lípidos, Hipercolesterolemia Familiar, Nutrición Clínica, medicina interna

Medicina, UNIVERSIDAD AUTONOMA DE MADRID. España, 1994
Nutrición Clínica, UNIVERSIDAD AUTONOMA INDOAMERICA. Chile, 1994
Médico Cirujano, UNIVERSIDAD DE VALPARAISO. Chile, 1987

Profesor Titular Part Time

UNIVERSIDAD DE VALPARAISO

Medicina

Valparaiso, Chile

1993 - 2003

Jede de Departamento Full Time

Clínica Las Condes

Santiago, Chile

2006 - At present

Director del Simposio Internacional en Hiperlipemias Genéticas y Riesgo Cardiovascular. Madrid 2008
Miembro del Comité de Colaboración Internacional Proyecto MED-PED (Make early diagnosis. prevent early diseases) para la detección y tratamiento de la Hipercolesterolemia Familiar Hetercigota
Director y Tutor del Curso “on-line” Actualización en el diagnóstico y tratamiento de las hiperlipemias familiares acreditado con 7,1 créditos por la Agencia Laín Entralgo (1ª y 2ª edición nacional y 1ª edición Castilla y León) 2012-2013
Director III Simposio Red Iberoamericana de Hipercolesterolemia Familiar. Santiago de Chile, 24-26 septiembre 2015.
Director del Simposio IAS-Grupo Chileno de Trabajo en Ateroesclerosis en el Congreso Interamericano de Cardiología, Santiago de Chile 6 de diciembre 2015.
Director del Simposio IAS-Grupo Chileno de Trabajo en Ateroesclerosis en las XI Jornadas de Nutrición Clínica, Obesidad y Metabolismo. El reto de la prevención cardiovascular. Santiago de Chile 20 de mayo de 2016
Director del 1 Curso de la Sociedad Médica de Santiago y Grupo Chileno de Trabajo en Ateroesclerosis. Actualización en el manejo de los factores de riesgo cardiovascular: De la teoría a la práctica clínica. Santiago de Chile 16 de junio de 2016.
Director del 2 Curso de la Sociedad Médica de Santiago y Grupo Chileno de Trabajo en Ateroesclerosis. Actualización en el manejo de los factores de riesgo cardiovascular: De la teoría a la práctica clínica. Santiago de Chile 14,15 de julio de 2017.
Director de Curso de Dislipidemias Fundación Lucas Sierra; Viña del Mar 13 y 14 abril 2018
Líder Nacional Proyecto European Atherosclerosis Society Familial Hypercholesterolemia Studies Collaboration (EAS FHSC 2017-2019)
Member at large (miembro del Board) de la International Atherosclerosis Society• Socio Fundador y Miembro del Comité científico de la Fundación Hipercolesterolemia Familiar, España.
Coordinador del Registro Español de Hipercolesterolemia Familiar y del Estudio de seguimiento de una cohorte de familias con diagnóstico genético de Hipercolesterolemia Familiar (estudio SAFEHEART hasta el 2014)
Miembro del Board de la Asociación Red Iberoamericana de Hipercolesterolemia Familiar.
Colaborador Docente Universidad Autónoma de Madrid (2008-2014)
Director III Simposio Red Iberoamericana de Hipercolesterolemia Familiar. Santiago de Chile, 24-26 septiembre 2015.
Director del Simposio IAS-Grupo Chileno de Trabajo en Ateroesclerosis en el Congreso Interamericano de Cardiología, Santiago de Chile 6 de diciembre 2015.
Director del Curso “Actualización en el manejo de los factores de riesgo cardiovascular: De la teoría a la práctica clínica” años 2016,2017,2018, 2020- 2024 organizado por la Corporación Grupo Chileno de Trabajo en Ateroesclerosis.
Director Academia de Obesidad (8 versiones) de la Corporación Grupo Chileno de Trabajo en Ateroesclerosis
Coautor Orientación Técnica del Ministerio de Salud de Chile en el diagnóstico y tratamiento de las dislipidemias (2018).
Governor para Chile de la International Society Cardiovascular Pharmacotherapy (2023-)
Líder Nacional Proyecto European Atherosclerosis Society Familial Hypercholesterolemia Studies Collaboration (EAS FHSC 2017-2024)
Member at large (miembro del Board) de la International Atherosclerosis Society (2019-2021)
Miembro del Equipo Obesidad Chile
Revisor de Revistas Indexadas: J Clin Lipidol, Eur J Prev Cardiol, Atherosclerosis, Eur Heart J, Rev Med Chile, Am J Prev Cardiol, entre otras.


Cholesterol-lowering therapy from childhood/adolescence and long-term outcomes in familial hypercholesterolaemia: the SAFEHEART study Vallejo-Vaz, Antonio J.; Arroyo-Olivares, Raquel; Alonso, Rodrigo; Gidding, Samuel S.; Muniz-Grijalvo, Ovidio; de Andres, Raimundo; Diaz-Diaz, Jose L.; Fuentes, Francisco; Beltran-Romero, Luis M.; Cepeda, Jose M.; et al. Article ISI EUROPEAN HEART JOURNAL (2026)
Functional analysis from ex-vivo characterization of LDLR exon 13-15 duplication associated to familial hypercholesterolemia Martinez, Catalina; Alarcon, Carolina; Radojkovic, Claudia; Cid, Andrea; Vilches, Noemi; Guzman-Gutierrez, Enrique; Saez, Katia; Alonso, Rodrigo; Sanchez, Andrea Article ISI FRONTIERS IN ENDOCRINOLOGY (2026)
A multi-society Delphi consensus statement on the diagnosis of familial chylomicronemia syndrome Aguilar-Salinas, CA; Alonso, R; Berg, G; Pinedo, AAC; Corral P.; Bautista, IC; Izar M.C.; Mendivil, CO; Nogueira J.P.; Roman-Gonzalez A.; et al. Article ISI Archives of Endocrinology and Metabolism (2025)
Application of a Pilot Screening Program for Familial Hypercholesterolemia in a High-Complexity Hospital Center Radojkovic, Claudia; Honorato, Paula; Portino, Rene; Martinez, Catalina; Saez, Katia; Bourbon, Mafalda; Munoz, Isabel; Alvarado, Cristobal; Guzman, Enrique; Bustos, Paulina; et al. Article ISI Revista Medica de Chile (2025)
Clinical profile of familial hypercholesterolemia phenotype in adults attended in primary care in a large healthcare area Gijón-Conde, T; Banegas, JR; Sánchez, CF; Alonso, R; Mata P. Article ISI Atherosclerosis (2025)
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry Elshorbagy, A; Vallejo-Vaz A.J.; Barkas, F; Lyons A.R.M.; Stevens C.A.T.; Dharmayat K.I.; Catapano A.L.; Freiberger T.; Hovingh G.K.; Mata P.; et al. Article ISI European Heart Journal (2025)
Phenotypic and molecular characterization of the exon 13-15 duplication in LDLR: Implications for familial hypercholesterolemia AbarzÃºa; D.; Radojkovic; C.; Quintana; S.; MartÃnez; C.; Barriga; N.; Alonso; R.; Guzman; E.; Burgos; C.F.; SÃ¡nchez; A Article ISI Journal of Clinical Lipidology (2025)
Age- and sex-based heterogeneity in coronary artery plaque presence and burden in familial hypercholesterolemia: A multi-national study Nasir, K; Mszar, R; Cainzos-Achirica, M; Grandhi, GR; Tromp, TR; Alonso, R; Bittencourt M.S.; Bruckert E.; Diaz-Diaz J.L.; Gallo A.; et al. Article ISI (2024)
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study Elshorbagy, A; Lyons A.R.M.; Vallejo-Vaz A.J.; Stevens C.A.T.; Dharmayat K.I.; Brandts, J; Catapano A.L.; Freiberger T.; Hovingh G.K.; Mata P.; et al. Article ISI (2024)
Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients Escate, R; Padró, T.; De Isla L.P.; Fuentes F.; Alonso, R; Mata P.; Badimon L. Article ISI (2024)
Core data set for real world data in multiple sclerosis: customization for latin america from a global task force recommendation Rojas J.I.; Gracia F.; Parciak, T; Alonso, R; Becker J.; Treviño-Frenk, I; Alonso-Serena, M; Giunta, D; Abad P.; Carnero-Contentti, E; et al. Article ISI (2024)
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study Dharmayat K.I.; Vallejo-Vaz A.J.; Stevens C.A.T.; Brandts, JM; Lyons A.R.M.; Groselj U.; Abifadel M.; Aguilar-Salinas, CA; Alhabib K.; Alkhnifsawi M.; et al. Article ISI (2024)
Features and behaviours for weight loss in the Chilean cohort with obesity from the ACTION study Cuevas A.; Pardo F.; Alonso, R; Barros E.; Rendon A. Article ISI (2024)
Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study Alonso, R; Arroyo-Olivares R.; Diaz-Diaz J.L.; Fuentes-Jimenez F.; Arrieta F.; de Andrés, R; Gonzalez-Bustos P.; Argueso R.; Martin-Ordiales, M; Martinez-Faedoj, C; et al. Article ISI (2024)
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study De Isla L.P.; Vallejo-Vaz A.J.; Watts G.F.; Muñiz-Grijalvo, O; Alonso, R; Diaz-Diaz J.L.; Arroyo-Olivares R.; Aguado R.; Argueso R.; Mauri, M; et al. Article ISI (2024)
Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study Alonso, R; Arroyo-Olivares R.; Muñiz-Grijalvo, O; Díaz-Díaz, DJL; Munoz-Torrero, JS; Romero, MJ; de Andrés, R; Zambon, D; Manas, MD; Fuentes-Jimenez F.; et al. Article ISI EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)
A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort Perez De Isla L.; Watts G.F.; MuÃƒÂ±iz-Grijalvo O.; DÃƒÂaz-DÃƒÂaz J.L.; Alonso, R; ZambÃƒÂ³n D.; Fuentes-Jimenez F.; Mauri, M; PadrÃƒÂ³ T.; Vidal-Pardo J.I.; et al. Article SCOPUS European Journal of Preventive Cardiology (2022)
Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients De Isla L.P.; Alonso, R; Argueso R.; Muñiz-Grijalvo, O; Alvarez-Baños, P; Badimon L.; Watts G.F.; Mata P. Article ISI SCOPUS JOURNAL OF CLINICAL LIPIDOLOGY (2022)
Adherence to a Mediterranean diet, dyslipidemia and inflammation in familial hypercholesterolemia Antoniazzi L.; Arroyo-Olivares R.; Bittencourt M.S.; Tada M.T.; Lima I.; Jannes C.E.; Krieger J.E.; Pereira, AC; Quintana-Navarro G.; MuÃƒÂ±iz-Grijalvo O.; et al. Article SCOPUS Nutrition, Metabolism and Cardiovascular Diseases (2021)
Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study PÃƒÂ©rez De Isla L.; Alonso, R; GÃƒÂ³mez de Diego J.J.; MuÃƒÂ±iz-Grijalvo O.; DÃƒÂaz-DÃƒÂaz J.L.; ZambÃƒÂ³n D.; Miramontes J.P.; Fuentes F.; De AndrÃƒÂ©s R.; Werenitzky J.; et al. Article SCOPUS Atherosclerosis (2021)
Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience Alonso, R; MuÃƒÂ±iz-Grijalvo O.; DÃƒÂaz-DÃƒÂaz J.L.; ZambÃƒÂ³n D.; De AndrÃƒÂ©s R.; Arroyo-Olivares R.; Fuentes-Jimenez F.; MuÃƒÂ±oz-Torrero J.S.; Cepeda J.; Aguado R.; et al. Article SCOPUS Journal of Clinical Lipidology (2021)
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Vallejo-Vaz A.J.; Stevens C.A.T.; Lyons A.R.M.; Dharmayat K.I.; Freiberger T.; Hovingh G.K.; Mata P.; Raal F.J.; Santos R.D.; Soran H.; et al. Article SCOPUS The Lancet (2021)
Identification of genetic variants associated with familial hypercholesterolemia in Chilean children and adolescents andrea sanchez; Paulina Bustos; Paula Honorato; Cinthia Elim-Jannes; Natalia Barriga; Guillermo Ibieta; Rodrigo Alonso; Claudia Radojkovic; Sylvia Asenjo Article ISI SCIELO SCOPUS Revista medica de Chile (2021)
Lipoprotein(a), LDL-cholesterol, and hypertension: Predictors of the need for aortic valve replacement in familial hypercholesterolaemia PÃƒÂ©rez De Isla L.; Watts G.F.; Alonso, R; DÃƒÂaz-DÃƒÂaz J.L.; MuÃƒÂ±iz-Grijalvo O.; ZambÃƒÂ³n D.; Fuentes F.; De AndrÃƒÂ©s R.; PadrÃƒÂ³ T.; LÃƒÂ³pez-Miranda J.; et al. Article SCOPUS European Heart Journal (2021)
Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in Iberoamerica Alves A.C.; Alonso, R; Diaz-Diaz J.L.; Medeiros A.M.; Jannes C.E.; Merchan A.; Vasques-Cardenas N.A.; Cuevas A.; Chacra A.P.; Krieger J.E.; et al. Article SCOPUS Arteriosclerosis, Thrombosis, and Vascular Biology (2020)
Adults with familial hypercholesterolaemia have healthier dietary and lifestyle habits compared with their non-affected relatives: the SAFEHEART study Arroyo-Olivares R.; Quintana-Navarro G.; Fuentes-JimÃ©nez F.; Mata N.; MuÃ±iz-Grijalvo O.; DÃaz-DÃaz J.L.; ZambÃ³n D.; GarcÃa-Cruces J.; Garrido-Sanjuan J.A. Article ISI SCOPUS PUBLIC HEALTH NUTRITION (2019)
Diagnosis and Management of Statin Intolerance cuevas, ada; Cafferata, Alberto Article ISI SCOPUS JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2019)
Liquid Biopsy of Extracellular Microvesicles Maps Coronary Calcification and Atherosclerotic Plaque in Asymptomatic Patients With Familial Hypercholesterolemia Chiva-Blanch G. Article ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia Ellis, Katrina L.; Fuentes, Francisco Article ISI SCOPUS JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Atherosclerotic cardiovascular disease risk assessment in familial hypercholesterolemia: does one size fit all? Article SCOPUS Current Opinion in Lipidology (2018)
Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study De Isla L.P.; Muñiz-Grijalvo, O; Zambon, D; de Diego J.J.G.; Gonzalez-Estrada, A; Mata N.; Barreiro, M; de Andrés, R; Argues, R; Gotarredona, MPS; et al. Article ISI SCOPUS JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Familial Hypercholesterolaemia Diagnosis and Management De Isla L.P. Article WOS-ESCI SCOPUS EUROPEAN CARDIOLOGY REVIEW (2018)
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) De Marco, M; Stevens C.A.T.; Akram, A; Freiberger T.; Hovingh G.K.; Kastelein J.J.P.; Raal F.J.; Santos R.D.; Soran H.; Abifadel M.; et al. Article ISI SCOPUS ATHEROSCLEROSIS (2018)
Response to letter entitled Coronary computed tomography angiogram in familial hypercholesterolemia: A double edge sword Perez de Isla, Leopoldo Article ISI SCOPUS JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Sleeve Gastrectomy Outcomes in Patients with BMI Between 30 and 35-3 Years of Follow-Up Lamoza, P; Luna, E; Parra F.; Alonso, R Article ISI OBESITY SURGERY (2018)
Atherogenic Dyslipidemia in Latin America: Prevalence, causes and treatment Expert's position paper made by The Latin American Academy for the Study of Lipids (ALALIP) Endorsed by the Inter-American Society of Cardiology (IASC), the South American Society of Cardiology (SSC), the Pan-American College of Endothelium (PACE), and the International Atherosclerosis Society (IAS) Ponte-Negretti, Carlos I.; Isea-Perez, Jesus E.; Lorenzatti, Alberto J.; Lopez-Jaramillo, Patricio; Wyss-Q, Fernando Stuardo; Pinto, Xavier; Lanas, Fernando; Medina, Josefina; Machado-H, Livia T.; Acevedo, Monica; et al. Article ISI INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry Article ISI REVISTA ESPANOLA DE CARDIOLOGIA (2017)
Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries Vasques-Cardenas N.A.; Alves A.C.; Medeiros A.M.; Jannes C.E.; Krieger J.E.; Schreier L.; Perez De Isla L.; Magaña-Torres M.T.; Dell Oca N.; Bañares V.G.; et al. Article ISI SCOPUS JOURNAL OF CLINICAL LIPIDOLOGY (2017)
Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia Lázaro P.; Blasco A.J. Article ISI SCOPUS JOURNAL OF CLINICAL LIPIDOLOGY (2017)
Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry Alves A.C. Article ISI SCOPUS ATHEROSCLEROSIS (2017)
Plasma PCSK9 measurement by liquid chromatography-Tandem mass spectrometry and comparison with conventional ELISA Croyal M.; Fall F.; Thédrez A.; Ouguerram K.; Ferchaud-Roucher V.; Aguesse A.; Billon-Crossouard S.; Nobécourt E. Article ISI SCOPUS JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
Predicting Cardiovascular Events in Familial Hypercholesterolemia The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study) Fernández-Pérez C.; Saltijeral A.; Piedecausa M.; Galiana J.; Brea Á.; Sanchez Muñoz-Torrero J.F.; Argueso R. Article ISI SCOPUS CIRCULATION (2017)
ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia Cubedo, Judit; Padro, Teresa; Badimon, Lina Article ISI JOURNAL OF LIPID RESEARCH (2016)
Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia 5-Year SAFEHEART Registry Follow-Up De Isla L.P.; Alonso, R; Mata N.; Cerezo, AS; Muniz, O; Fuentes F.; Diaz-Diaz J.L.; de Andrés, R; Zambon, D; Rubio-Marin, P; et al. Article ISI SCOPUS JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry Arrieta F.; Saenz, P; Vidal-Pardo J.I.; Almagro, F; Prieto-Matos, P; Miramontes J.P.; Rodriguez-Urrego, J Article ISI SCOPUS JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study) Aguado R.; Mosquera, D; Manjon, L; Miramontes J.P. Article ISI SCOPUS ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia Moyon, T Article ISI SCOPUS ATHEROSCLEROSIS (2016)
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration Ceska R.; Do, CT; Ezhov, MV; Fras, Z; Gaita D.; Lin, N; Majano, N; Marais A.D.; Mirrakhimov, E; Miserez A.R.; et al. Article ISI SCOPUS ATHEROSCLEROSIS SUPPLEMENTS (2016)
Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes Cerrato F.; Fernandez-Suarez, M. E.; Alonso, M.; Vazquez C.; Lasuncion, M. A. Article ISI BRITISH JOURNAL OF PHARMACOLOGY (2015)
Diagnosis and treatment of familial hypercholesterolemia in Spain: Consensus document Gonzalez-Juanatey, Jose R.; Badimon, Lina; Teresa Munoz, Maria; Galve, Enrique; Irigoyen, Luis; Fuentes-Jimenez, Francisco; Dalmau, Jaime; Perez-Jimenez, Francisco; otros colaboradores Article ISI ATENCION PRIMARIA (2015)
Familial hypercholesterolaemia: A global call to arms Vallejo-Vaz A.J.; Seshasai, SRK; Della Cole,; Hovingh G.K.; Kastelein J.J.P.; Mata P.; Raal F.J.; Santos R.D.; Soran H.; Abifadel M.; et al. Article ISI SCOPUS Atherosclerosis (2015)
High levels of TSP1(+)/CD142(+) platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis Padro, Teresa; Badimon, Lina Article ISI (2015)
Homozygous familial hypercholesterolemia. First case in Spain treated with lomitapide, an inhibitor of the synthesis of lipoproteins with apolipoprotein B Alonso y Gregorio, Moises; de Andres, Raimundo Article ISI MEDICINA CLINICA (2015)
rs11613352 Polymorphism (TT Genotype) Associates with a Decrease of Triglycerides and an Increase of HDL in Familial Hypercholesterolemia Patients Aledo, Rosa; Padro, Teresa; Badimon, Lina Article ISI REVISTA ESPANOLA DE CARDIOLOGIA (2015)
Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study Fuentes, Francisco; Alcala-Diaz, Juan F.; Watts, Gerald F.; Muniz, Ovidio; Diaz-Diaz, Jose L.; Munoz-Torrero, Juan F. Sanchez; Brea, Angel; Galiana, Jesus; Figueras, Rosaura; Aguado, Rocio; et al. Article ISI INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Treating homozygous familial hypercholesterolemia in a real-world setting: Experiences with lomitapide van Lennep, JR; Averna, M; Alonso, R Article ISI SCOPUS Journal of Clinical Lipidology (2015)
Familial combined hyperlipidemia: Consensus document Ruiz-Garcia, Antonio; Gonzalez, Noemi; Gijon-Conde, Teresa; Moron, Ignacio; Arranz, Ezequiel; Argueso, Rosa Article ISI ATENCION PRIMARIA (2014)
Quality of life in a cohort of familial hypercholesterolemia patients from the south of Europe Banegas, Jose R.; Zambon, Daniel Article ISI EUROPEAN JOURNAL OF PUBLIC HEALTH (2014)
rs1801275 Interleukin-4 receptor alpha polymorphism in familial hypercholesterolemia Rivas, Maria D.; Joya-Vazquez, Pedro; Padro, Teresa Article ISI JOURNAL OF CLINICAL LIPIDOLOGY (2014)
Influence of Lipoprotein (a) on Inflammatory Biomarkers in Metabolic Syndrome Sanchez Munoz-Torrero, Juan Francisco; Rivas, Dolores; Crespo, Leandro; Costo, Alberto; Roman, Montana; Martin, Carlos Article ISI SOUTHERN MEDICAL JOURNAL (2012)
Omega-3 fatty acids and blood pressure Cabo, Jorge Article ISI BRITISH JOURNAL OF NUTRITION (2012)
Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform Defesche, Joep C.; Stef, Marianne; Mata, Nelva; Gomez-Enterria, Pilar; Martinez-Faedo, Ceferino; Forga, Lluis Article ISI CLINICAL BIOCHEMISTRY (2009)
Molecular diagnosis and combined lipid lowering therapy of heterozygous familial hypercholesterolemia. Report of one case Arteaga A.; Cuevas A.; Rigotti, A; González, F; Castillo S.; Mata P.; Alonso, R Article ISI REVISTA MEDICA DE CHILE (2007)
Comparison of DNA array platform vs DNA sequencing as genetic diagnosis tools for familial hypercholesterolemia Tejedor, Diego; Castillo, Sergio; Mozas, Pilar; Jimenez, Elisa; Tejedor, M. Teresa; Artieda, Marta; Mata, Pedro; Simon, Laureano; Pocovi, Miguel Article ISI CLINICAL CHEMISTRY (2006)
High frequency of APOB gene mutations causing familial hypobetalipoproteinaemia in patients of Dutch and Spanish descent Fouchier, SW; Sankatsing, RR; Peter J.; Pocovi, M; Kastelein J.J.P.; Defesche, JC Article ISI JOURNAL OF MEDICAL GENETICS (2005)
Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia Tejedor, D; Mozas, P; Tejedor, MT; Artieda, M; Simon L.; Spanish FH Grp Article ISI CLINICAL CHEMISTRY (2005)
Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation Civeira, F; Merino-Ibarra, E; Cenarro, A; Artied, M; Martin-Fuentes, P; Spanish Familial Hypercholesterole Article ISI ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)


Persistence to long-term PCSK9 inhibitors treatment and its effectiveness in familial hypercholesterolemia: data from the SAFEHEART study Alonso, R; Arroyo-Olivares R.; Muñiz-Grijalvo, O; Diaz-Diaz J.L.; Munoz-Torrero, JS; Zambon, D; Fuentes-Jimenez F.; Romero, MJ; Aguado R.; Alvarez-Baños, P; et al. Abstract ISI EUROPEAN HEART JOURNAL (2022)


Tratamiento de la dislipidemia aterogénica Alonso K, Rodrigo; Ada Cuevas M BookSection (2021)


The Genetics of Obesity Alonso, R; Farias, M; Ãlvarez V.; Cuevas A. BookWhole SCOPUS Translational Cardiometabolic Genomic Medicine (2015)


Bempedoic acid: A new player in lipid-lowering therapies Cuevas A.; Alonso, R Editorial SCOPUS Journal of Clinical Lipidology (2020)


Familial hypercholesterolemia, lipoprotein(a) and atherosclerosis Alonso, R; Mata P. EditorialMaterial ISI SCOPUS Medicina Clinica (2023)
What are the controversies and appropriate guidance for cascade screening for lipoprotein(a)? Alonso, R; Mata P. EditorialMaterial ISI SCOPUS Expert Review of Cardiovascular Therapy (2023)
Extreme xanthomatosis in patients with both familial hypercholesterolemia and cerebrotendinous xanthomatosis Huijgen R.; Peter J.; Alonso, R; Cuevas A.; Duran M. EditorialMaterial ISI SCOPUS Clinical Genetics (2012)


Ibero-American position statement on therapeutic recommendations for the preventive management of cardiovascular complications in latin-American patients with type 2 diabetes mellitus: consensus of the prevention council of the inter-American society of cardiology (SIAC-PREVENT) Wyss, Fernando; Ullauri, Vladimir; Teran, Joffre Lara; Arteaga-Arellano, Andres; Gomez-Martin, Carolina; Lopez-Santi, Ricardo; Perez, Gonzalo; Madrigal, Carlos Armando; Ger, Mayra; Piskorz, Daniel; et al. Review ISI DIABETOLOGY & METABOLIC SYNDROME (2026)
Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime? Alonso, R; ArgÃ¼eso R.; Ãlvarez-BaÃ±os P.; MuÃ±iz-Grijalvo O.; Diaz-Diaz J.L.; Mata P. Review SCOPUS Current Atherosclerosis Reports (2022)
Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion Santos R.D.; Lorenzatti A.; Corral P.; Nogueira J.P.; Cafferata A.M.; Aimone D.; LourenÃƒÂ§o C.M.; Izar M.C.; Lima J.G.; Lottenberg A.M.; et al. Review SCOPUS Journal of Clinical Lipidology (2021)
Dyslipidemia and aortic valve disease Mata P.; Alonso, R; De Isla L.P.; Badimon L. Review ISI SCOPUS Current Opinion in Lipidology (2021)
The relationship between obesity and depressive states Alonso, R; Olivos C. Review SCOPUS Revista Medica Clinica Las Condes (2020)
Statin-associated muscle symptoms: position paper from the Luso-Latin American Consortium Faria Neto J.R.; Carvalho L.S.F.D.; Lorenzatti A.; Elikir G.; Morales Villegas E.C.; Bodanese L.C.; Ruiz A.J.; Rocha V.Z.; Coelho O.R.; Assad M.H.V.; et al. Review ISI SCOPUS CURRENT MEDICAL RESEARCH AND OPINION (2017)
Cardiac computed tomography imaging in familial hypercholesterolaemia: Implications for therapy and clinical trials Nieman K.; Budoff M.J.; Ogura M.; Nohara A.; Sullivan, DR; Watts G.F.; Bell D.A.; Karlezi R.A.; Miname M.H.; Gidding S.S.; et al. Review SCOPUS Current Opinion in Lipidology (2015)
New lipid lowering agents Cuevas A.; Farias, MM; Alonso, R Review ISI REVISTA MEDICA DE CHILE (2014)
Nuevos fármacos para el tratamiento de la hipercolesterolemia Ada Cuevas; Marï¿½a Magdalena Farï¿½as; Rodrigo Alonso Review SCIELO SCOPUS REVISTA MEDICA DE CHILE (2014)
Metabolic Syndrome. Clinical and pathophysiological basis for a rational therapeutical approach Martinez, G.; Alonso, R; Novik V. Review ISI REVISTA MEDICA DE CHILE (2009)